St Louis, MISSOURI3 Active Studies

Sarcoma Soft Tissue Clinical Trials in St Louis, MISSOURI

Find 3 actively recruiting sarcoma soft tissue clinical trials in St Louis, MISSOURI. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
288
Enrolling

Recruiting Sarcoma Soft Tissue Studies in St Louis

About Sarcoma Soft Tissue Clinical Trials in St Louis

Soft tissue sarcomas are rare cancers that develop in the soft tissues of the body including muscle, fat, blood vessels, and tendons. There are more than 50 subtypes, each with different characteristics. Treatment includes surgery, radiation, and chemotherapy, with newer targeted therapies under investigation.

There are currently 3 sarcoma soft tissue clinical trials recruiting participants in St Louis, MISSOURI. These studies are seeking a combined 288 participants. Research is being sponsored by St. Jude Children's Research Hospital, Philogen S.p.A., Washington University School of Medicine. Clinical trial participation is free and participants receive study-related medical care at no cost.

Sarcoma Soft Tissue Clinical Trials in St Louis — FAQ

Are there sarcoma soft tissue clinical trials in St Louis?

Yes, there are 3 sarcoma soft tissue clinical trials currently recruiting in St Louis, MISSOURI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in St Louis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the St Louis research site will contact you about next steps.

Are clinical trials in St Louis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many St Louis studies also compensate for your time and travel.

What sarcoma soft tissue treatments are being tested?

The 3 active trials in St Louis are testing new therapies including novel drugs, biologics, and treatment approaches for sarcoma soft tissue.

Data updated March 2, 2026 from ClinicalTrials.gov